|Day Low/High||1.25 / 1.43|
|52 Wk Low/High||1.25 / 7.54|
Company Adopts Omnibus Equity Incentive Plan and Policy to Better Align with Shareholder Values and Facilitate Growth
Study is currently enrolling MGMT-unmethylated Avastin (bevacizumab)-naive recurrent GBM patients at the University of Texas MD Anderson Cancer Center
Here's how to trade five stocks that are ready to break out and trade higher from current levels.
Biotech investors have not had much to cheer about in 2016.
DelMar Pharmaceuticals enjoyed a bit of good news this week after its shares were uplisted to the Nasdaq Capital Market this week.
SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued an update note on DelMar ...